8-K: BioAdaptives Inc. Changes Auditors Following SEC Suspension of BF Borgers

BioAdaptives Inc. has dismissed BF Borgers as its auditor after the firm was suspended by the SEC and appointed Boladale Lawal & Co as its new independent auditor.

Summary

• BioAdaptives Inc. dismissed BF Borgers, CPA PC as their independent registered auditing firm on May 8, 2024.
• This decision was made after the SEC announced settled enforcement proceedings against BF Borgers on May 3, 2024, which resulted in the firm being permanently suspended from practicing as accountants and PCAOB auditors on SEC filings.
• BioAdaptives did not include a letter from BF Borgers regarding their agreement with the disclosure, as BF Borgers is not permitted to practice before the SEC.
• On May 11, 2024, BioAdaptives appointed Boladale Lawal & Co as their new independent registered PCAOB firm.
• Boladale Lawal & Co will perform independent audit services for the fiscal year ending December 31, 2024, and review the quarterly reports for 2024.
• They will also audit the balance sheet as of December 31, 2023, and the related financial statements for the year then ended.

Sentiment

Score: 3

Explanation: The document reflects a negative event (auditor dismissal due to SEC suspension) which raises concerns about past financial reporting. The company has taken steps to rectify the situation, but the overall sentiment is negative.

Positives

• The company has acted swiftly to replace their auditor after the SEC suspension of BF Borgers.
• The appointment of a new auditor ensures the company will meet its financial reporting obligations.

Negatives

• The dismissal of BF Borgers was due to the firm's suspension by the SEC, which could raise concerns about the previous audits.
• The company was unable to obtain a letter from BF Borgers regarding their agreement with the disclosure.

Risks

• The change in auditors could lead to increased scrutiny of the company's past financial statements.
• There is a risk that the new auditor may identify issues that were not previously detected.

Future Outlook

The company will be working with Boladale Lawal & Co to complete the audit of the 2023 financials and the 2024 fiscal year.

Management Comments

• BioAdaptives Inc. wishes to state also that it did not include a letter from BFB, its prior auditor, stating whether BFB agrees with this item 304 disclosure, as BFB, their prior auditor is not currently permitted to appear or practice before the Commission.

Industry Context

The change in auditors is a direct result of regulatory action against BF Borgers, which is a significant event in the accounting industry. Companies are expected to maintain high standards of financial reporting and are required to use auditors that are in good standing with the SEC.

Comparison to Industry Standards

• The dismissal of BF Borgers due to SEC action is not a common occurrence, as most auditing firms maintain compliance with regulatory standards.
• Companies like BioAdaptives typically engage reputable auditing firms with a proven track record of compliance and accuracy.
• The appointment of Boladale Lawal & Co is a standard response to the situation, as companies are required to have an independent auditor to ensure the integrity of their financial statements.

Stakeholder Impact

• Shareholders may be concerned about the change in auditors and the potential implications for the company's financial statements.
• The company's reputation may be negatively impacted by the dismissal of their previous auditor due to SEC action.

Next Steps

• Boladale Lawal & Co will complete the audit of the 2023 financials.
• Boladale Lawal & Co will perform independent audit services for the fiscal year ending December 31, 2024.
• Boladale Lawal & Co will review the quarterly reports for 2024.

Key Dates

Keywords

auditor, PCAOB, BF Borgers, Boladale Lawal & Co, SEC, audit, financial statements, accounting